文献速递呼吸道感染慢阻肺哮喘

CRISPR系统在呼吸健康领域的应用:基因组编辑进入新「红笔」时代

Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
PubMed 文献 · Respirology · 2019-03-18

本文综述CRISPR/Cas系统在呼吸疾病研究中的应用,涵盖流感感染、急性气管支气管炎、肺炎、结核、慢阻肺、哮喘、肺癌及鼻咽癌等。该系统可用于构建疾病 preclinical 模型、筛选致病基因与药物靶点,并有潜力修正致病基因突变与表观遗传标记,实现个体化治疗,但特异性与递送安全效率仍需解决。

要点

  • CRISPR/Cas可用于呼吸疾病临床前建模,揭示发病机制
  • 可用于筛选呼吸过程、发育与病理相关基因,发现新靶点
  • 有望修正致病突变与表观标记,结合干细胞重编程实现个体化治疗

核心结论

  • CRISPR/Cas系统为呼吸健康研究与治疗带来重要进展,相关突破预计将持续涌现。

研究设计与样本

  • 综述类:围绕CRISPR/Cas系统在呼吸健康研究与应用中的进展进行汇总,未报告检索范围与样本量。

主要发现

  • CRISPR/Cas可对呼吸疾病因果因素进行临床前建模,提供机制新见解。
  • CRISPR可筛选参与呼吸过程、发育与病理的基因,识别新的疾病驱动因素或药物靶点。
  • CRISPR/Cas有潜力修正导致呼吸疾病的基因突变并编辑表观遗传标记。

临床怎么用

  • 可将CRISPR/Cas用于呼吸疾病机制研究与靶点筛选,并探索与干细胞重编程和移植联合的个体化治疗。

局限性

  • CRISPR基因编辑是年轻研究领域,其特异性以及高效安全的递送方法仍需进一步解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory diseases, such as influenza infection, acute tracheal bronchitis, pneumonia, tuberculosis, chronic obstructive pulmonary disease, asthma, lung cancer and nasopharyngeal carcinoma, continue to significantly impact human health. Diseases of the lung and respiratory tract are influenced by environmental conditions and socio-economic factors; however, many of these serious respiratory disorders are also rooted in genetic or epigenetic causes. Clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins, isolated from the immune system of prokaryotes, provide a tool to manipulate gene sequences and gene expression with significant implications for respiratory research. CRISPR/Cas systems allow preclinical modelling of causal factors involved in many respiratory diseases, providing new insights into their underlying mechanisms. CRISPR can also be used to screen for genes involved in respiratory processes, development and pathology, identifying novel disease drivers or drug targets. Finally, CRISPR/Cas systems can potentially correct genetic mutations and edit epigenetic marks that contribute to respiratory disorders, providing a form of personalized medicine that could be used in conjunction with other technologies such as stem cell reprogramming and transplantation. CRISPR gene editing is a young field of research, and concerns regarding its specificity, as well as the need for efficient and safe delivery methods, need to be addressed further. However, CRISPR/Cas systems represent a significant step forward for research and therapy in respiratory health, and it is likely we will see the breakthroughs generated from this technology continue.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Moses C, Kaur P. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing. Respirology. 2019. PMID: 30883991. doi:10.1111/resp.13527

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。